牛牛AI助理已提取核心訊息
Cardio Diagnostics Holdings, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of February 1, 2024, at 11:00 A.M. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that Cardio Diagnostics Holdings has met all the necessary regulatory requirements to proceed with the issuance of securities.
Cardio Diagnostics Holdings, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of February 1, 2024, at 11:00 A.M. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that Cardio Diagnostics Holdings has met all the necessary regulatory requirements to proceed with the issuance of securities.
Cardio Diagnostics Holdings, Inc.取得了重要的里程碑，美國證券交易委員會（SEC）宣佈其S-3表格自2024年2月1日上午11點起生效。該表格是一份註冊聲明，允許公司向公衆發行各種證券。該表格的有效性表明，Cardio Diagnostics Holdings已滿足所有必要的監管要求，可以繼續發行證券。
Cardio Diagnostics Holdings, Inc.取得了重要的里程碑，美國證券交易委員會（SEC）宣佈其S-3表格自2024年2月1日上午11點起生效。該表格是一份註冊聲明，允許公司向公衆發行各種證券。該表格的有效性表明，Cardio Diagnostics Holdings已滿足所有必要的監管要求，可以繼續發行證券。
有用
沒用
